Compounds > 2-3-dihydro-1-4-dioxin-5-carboxylic-acid-[2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl]-ester

2-3-dihydro-1-4-dioxin-5-carboxylic-acid-[2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl]-ester and Malaria

2-3-dihydro-1-4-dioxin-5-carboxylic-acid-[2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl]-ester has been researched along with Malaria* in 1 studies

Other Studies

1 other study(ies) available for 2-3-dihydro-1-4-dioxin-5-carboxylic-acid-[2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl]-ester and Malaria

ArticleYear
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
    Science (New York, N.Y.), 2018, 12-07, Volume: 362, Issue:6419

    To discover leads for next-generation chemoprotective antimalarial drugs, we tested more than 500,000 compounds for their ability to inhibit liver-stage development of luciferase-expressing

    Topics: Antimalarials; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Humans; Malaria; Mitochondria; Plasmodium

2018